When the patient presented with active disease in the liver, mutations started to be picked up in the plasma samples 2 months later, with an overall trend of increasing mutation numbers, as well as increasing allele frequencies, which we considered as an indication of increased tumor burden.
← all excerpts
Case report: 16-yr life history and genomic evolution of an ER<sup>+</sup> HER2<sup>-</sup> breast cancer.
1
—
—